{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:26:37Z","timestamp":1792661197109,"version":"4.5.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1097\/iae.0b013e3182877585","type":"journal-article","created":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T03:46:32Z","timestamp":1360899992000},"page":"975-981","source":"Crossref","is-referenced-by-count":90,"title":["POVIDONE\u2013IODINE CONTACT TIME AND LID SPECULUM USE DURING INTRAVITREAL INJECTION"],"prefix":"10.1097","volume":"33","author":[{"given":"Duncan A.","family":"Friedman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John O.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Emond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Mcgwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210130","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00006982-200410001-00002","article-title":". Evolving guidelines for intravitreous injections.","volume":"24","author":"Aiello","year":"2004","journal-title":"Retina"},{"key":"R2-13-20210130","first-page":"484","article-title":"Safety of intravitreous fomivirsen for treatment of cytomegalovirus retinitis in patients with AIDS.","volume":"133","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R3-13-20210130","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/IAE.0b013e31819d2591","article-title":". Infectious endophthalmitis after intravitreal injection of antiangiogenic agents.","volume":"29","author":"Diago","year":"2009","journal-title":"Retina"},{"key":"R4-13-20210130","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/IAE.0b013e31821067c4","article-title":". Endophthalmitis after intravitreal vascular corrected endothelial growth factor antagonists: a six-year experience at a university referral center.","volume":"31","author":"Moshfeghi","year":"2011","journal-title":"Retina"},{"key":"R5-13-20210130","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ajo.2011.07.002","article-title":"Prophylaxis for endophthalmitis following intravitreal injection: antisepsis and antibiotics.","volume":"152","author":"Wykoff","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"R6-13-20210130","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/sj.eye.6702683","article-title":". Acute endophthalmitis following intravitreal bevacizumab (Avastin) injection.","volume":"21","author":"Aggio","year":"2007","journal-title":"Eye (Lond)"},{"key":"R7-13-20210130","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ajo.2007.04.011","article-title":"The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials.","volume":"144","author":"Bhavsar","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R8-13-20210130","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0002-9394(03)00483-5","article-title":". Acute endophthalmitis following intravitreal triamcinolone acetonide injection.","volume":"136","author":"Moshfeghi","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R9-13-20210130","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00006982-200310000-00014","article-title":". Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection.","volume":"23","author":"Nelson","year":"2003","journal-title":"Retina"},{"key":"R10-13-20210130","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ajo.2007.12.036","article-title":". Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting.","volume":"145","author":"Pilli","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R11-13-20210130","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/archopht.121.9.1279","article-title":". Noninfectious endophthalmitis associated with intravitreal triamcinolone injection.","volume":"121","author":"Roth","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R12-13-20210130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00417-007-0660-z","article-title":". Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES).","volume":"246","author":"Wu","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R13-13-20210130","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1136\/bjo.2007.132597","article-title":". Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial.","volume":"92","author":"Singerman","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R15-13-20210130","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/IAE.0b013e3181884fd2","article-title":". Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab.","volume":"28","author":"Fintak","year":"2008","journal-title":"Retina"},{"key":"R17-13-20210130","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00006982-200410000-00002","article-title":"Risks of intravitreous injection: a comprehensive review.","volume":"24","author":"Jager","year":"2004","journal-title":"Retina"},{"key":"R18-13-20210130","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.ophtha.2005.06.007","article-title":". A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.","volume":"112","author":"Cunningham","year":"2005","journal-title":"Ophthalmology"},{"key":"R20-13-20210130","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/archopht.123.5.613","article-title":". Acute endophthalmitis following cataract surgery: a systematic review of the literature.","volume":"123","author":"Taban","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R21-13-20210130","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/IAE.0b013e3181633fee","article-title":". Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection.","volume":"28","author":"Mason","year":"2008","journal-title":"Retina"},{"key":"R22-13-20210130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/IAE.0b013e3180307271","article-title":"Reducing the risk of endophthalmitis following intravitreal injections.","volume":"27","author":"Scott","year":"2007","journal-title":"Retina"},{"key":"R23-13-20210130","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/archophthalmol.2009.304","article-title":". Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials.","volume":"127","author":"Bhavsar","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"R24-13-20210130","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.ophtha.2010.12.014","article-title":"Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections.","volume":"118","author":"Kim","year":"2011","journal-title":"Ophthalmology"},{"key":"R25-13-20210130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ajo.2010.08.039","article-title":"Survey of intravitreal injection techniques among retinal specialists in the United States.","volume":"151","author":"Green-Simms","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"R27-13-20210130","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00006982-200410000-00003","article-title":"Minimizing the risk of endophthalmitis following intravitreous injections.","volume":"24","author":"Ta","year":"2004","journal-title":"Retina"},{"key":"R28-13-20210130","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0161-6420(91)32052-9","article-title":"Prophylaxis of endophthalmitis with topical povidone-iodine.","volume":"98","author":"Speaker","year":"1991","journal-title":"Ophthalmology"},{"key":"R29-13-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9394(14)71959-2","article-title":". Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study.","volume":"122","author":"Han","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"R30-13-20210130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archopht.1997.01100150359008","article-title":". The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis.","volume":"115","author":"Bannerman","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"R31-13-20210130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0161-6420(01)00899-5","article-title":"Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update.","volume":"109","author":"Ciulla","year":"2002","journal-title":"Ophthalmology"},{"key":"R32-13-20210130","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archopht.1984.01040030584025","article-title":"Chemical preparation of the eye in ophthalmic surgery. III. Effect of povidone-iodine on the conjunctiva.","volume":"102","author":"Apt","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"R33-13-20210130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10792-007-9073-6","article-title":"The effect of povidone iodine flush versus drops on conjunctival colonization before intravitreal injections.","volume":"27","author":"Safar","year":"2007","journal-title":"Int Ophthalmol"},{"key":"R34-13-20210130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10384-008-0517-y","article-title":". Preoperative disinfection of the conjunctival sac with antibiotics and iodine compounds: a prospective randomized multicenter study.","volume":"52","author":"Inoue","year":"2008","journal-title":"Jpn J Ophthalmol"},{"key":"R35-13-20210130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.87.2.163","article-title":". Comparison of 5 povidone-iodine solution against 1 povidone-iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study.","volume":"87","author":"Ferguson","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R36-13-20210130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ajo.2007.08.031","article-title":". A prospective randomized study to determine the efficacy of preoperative topical levofloxacin in reducing conjunctival bacterial flora.","volume":"145","author":"Mino de Kaspar","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R37-13-20210130","first-page":"577","article-title":"Povidone-iodine: its efficacy as a preoperative conjunctival and periocular preparation.","volume":"16","author":"Caldwell","year":"1984","journal-title":"Ann Ophthalmol"},{"key":"R38-13-20210130","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1755-3768.1994.tb07191.x","article-title":"Preoperative ocular disinfection by the use of povidone-iodine 5.","volume":"72","author":"Dereklis","year":"1994","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"R39-13-20210130","first-page":"263","article-title":"Preoperative antibiotic and povidone-iodine preparation of the eye.","volume":"23","author":"Grimes","year":"1991","journal-title":"Ann Ophthalmol"},{"key":"R40-13-20210130","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/archopht.1985.01050090092039","article-title":"Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic.","volume":"103","author":"Isenberg","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"R41-13-20210130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0002-9394(00)00651-6","article-title":"The effect of topical povidone-iodine, intraocular vancomycin, or both on aqueous humor cultures at the time of cataract surgery.","volume":"131","author":"Mendivil Soto","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R42-13-20210130","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jcrs.2007.08.035","article-title":"Prospective comparative evaluation of povidone-iodine (10 for 5 minutes versus 5 for 1 minute) as prophylaxis for ophthalmic surgery.","volume":"34","author":"Ta","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"R43-13-20210130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000310888","article-title":"Preoperative disinfection of the conjunctival sac in cataract surgery.","volume":"211","author":"Hara","year":"1997","journal-title":"Ophthalmologica"},{"key":"R44-13-20210130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1089\/jop.2006.22.54","article-title":". Risk of endophthalmitis after cataract surgery using different protocols for povidone- iodine preoperative disinfection.","volume":"22","author":"Wu","year":"2006","journal-title":"J Ocul Pharmacol Ther"},{"key":"R45-13-20210130","first-page":"196","article-title":". Reduction of preoperative conjunctival bacterial flora with the use of mupirocin nasal ointment.","volume":"104","author":"Alexandrou","year":"2006","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R46-13-20210130","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/JCM.15.4.635-639.1982","article-title":"Increased bactericidal activity of dilute preparations of povidone-iodine solutions.","volume":"15","author":"Berkelman","year":"1982","journal-title":"J Clin Microbiol"},{"key":"R47-13-20210130","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/IAE.0b013e31816b3180","article-title":". Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections.","volume":"28","author":"de Caro","year":"2008","journal-title":"Retina"},{"key":"R49-13-20210130","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0161-6420(99)90395-0","article-title":"Endophthalmitis in cataract surgery: results of a German survey.","volume":"106","author":"Schmitz","year":"1999","journal-title":"Ophthalmology"},{"key":"R50-13-20210130","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1755-3768.1987.tb07042.x","article-title":"Polyvinylpyrrolidone-iodine as a disinfectant in eye surgery for five years.","volume":"65","author":"Mork","year":"1987","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"R51-13-20210130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2106\/JBJS.J.00418","article-title":". A comparison of five treatment protocols for contaminated bone grafts in reference to sterility and cell viability.","volume":"93","author":"Bauer","year":"2011","journal-title":"J Bone Joint Surg Am"},{"key":"R52-13-20210130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000246038","article-title":"Cytotoxicity and sensitization of povidone-iodine and other frequently used anti-infective agents.","volume":"195","author":"Niedner","year":"1997","journal-title":"Dermatology"},{"key":"R53-13-20210130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0161-6420(89)32897-1","article-title":"Outpatient topical use of povidone-iodine in preparing the eye for surgery.","volume":"96","author":"Apt","year":"1989","journal-title":"Ophthalmology"},{"key":"R54-13-20210130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/01.ijg.0000137872.19942.cf","article-title":"Comparison of preoperative conjunctival bacterial flora in patients undergoing glaucoma or cataract surgery.","volume":"13","author":"de Kaspar","year":"2004","journal-title":"J Glaucoma"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0b013e3182877585","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T15:03:27Z","timestamp":1644332607000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201305000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3182877585","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717985541.793473952","asserted-by":"object"}]},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}